AHRP Position Statement on Mental Health Screening - FDA Hearing Re: Drug Advertising
Wed, 02 Nov 2005
FDA is holding public hearings (Nov 1, 2) Re: Direct-to-Consumer Promotion
of Medical Products
at: National Transportation Safety Board Boardroom and Conference Center 429 L'Enfant Plaza, SW., Washington, DC 2
Time: 9:00 --5:00.
Ellen Liversidge will submit testimony and represent the Alliance for Human Research Protection.
She will testify about a widely advertised Eli Lilly drug, Zyprexa (olanzapine), whose ads have made it a $4 billion blockbuster.
But failure to disclose the severe, potentially lethal effects of Zyprexa--including diabetes, hyperglycemia, pancreatitis, ketoacidosis, and diabetic coma--led to preventable deaths, including the death of her son, Rob, who died in 2002 of hyperglycemia.
See, front page news report, Baltimore Sun: http://www.ahrp.org/infomail/0303/20.php
The FDA did nothing--even after a Duke University study of FDA's Medwatch reports documented an alarming link to diabetes.
See: The Journal of the American Medical Association ( November 28, 2001) letter written by Dr. Elizabeth Koller, an FDA medical officer, Dr. P. Murali Doraiswamy, a Duke University psychiatrist warning that FDA's MedWatch data shows that patients taking either olanzapine or clozapine were 10 times more likely to become diabetic than the general population. http://jama.ama-assn.org/issues/current/ffull/jlt1128-4.html Vol. 286 No. 20.
In 2002, the Japanese Health and Welfare Ministry and UK Medicines Control Agency issued emergency Zyprexa warnings, the FDA still did nothing.
Indeed, Zyprexa is listed as a first line preferred treatment in the TMAP (Texas Medication Algorithm Project) prescribing guidelines.
Not until 2003 did the FDA require black box label warnings for Zyprexa and the other six antipsychotic drugs, alerting prescribers and patients to the possibility of the drugs' leading to the development of potentially fatal diabetes mellitus.
This year, Lilly agreed to pay a $690 million settlement for 8,000 Zyprexa-diabetes plaintiffs. However, the settlement is sealed so the drug's adverse effects are still not fully known to prescribing physicians or the public.
Ellen Liversidge will also present AHRP's Position Statement on Mental Health Screening: TeenScreen, a Marketing Strategy.
Contact: Vera Hassner Sharav
November 1, 2005
The ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) opposes government policies requiring or promoting mental health screening of America's infants, toddlers and school children. Our opposition is informed by scientific, legal, ethical, and common sense considerations.
1) The primary catalyst for both TeenScreen and for the prescribing guidelines, known as TMAP is market expansion.
Both TeenScreen and TMAP (the Texas Medication Algorithm Project) were recommended by the President's New Freedom Commission for Mental Health (NFC) Report.
To appreciate the financial stakes involved in the psychotropic drug business, one must only look at the staggering rate of return on investment. Companies that subsidized TMAP increased their rate of return hugely - not only in Texas, but nationwide.
|Drug Company||Expenditures on the Texas Medication Algorithm Project||Income from Texas Medicaid Expenditures for Psychiatric Drugs|
|Pfizer||$232 thousand||$ 233 MILLION|
|Janssen-J &J||$224 thousand||$ 272 MILLION|
|Eli Lilly||$109 thousand||$ 328 MILLION|
CBS-affiliate, KEYE News Investigation 
Dr. Peter J Weiden, who was a member of the TMAP expert consensus panel, has charged that the guidelines are based on "opinions, not data" and that "bias due to funding sources undermines the credibility of the guidelines since most of the guideline's authors have received support from the pharmaceutical industry." 
The invalid screening process of TeenScreen ensures that mostly healthy normal children will be brought into the government subsidized mental health dragnet. Once children acquire a psychiatric label, they are branded for life. For example, between 55% and 60% of foster children in at least three states--Texas , Massachusetts , and Florida --are on psychotropic drugs, starting as young as age three. Some children are on multiple "drug cocktails," as many as 16 drugs.
The treatments and interventions for psychiatric labels resulting from mental health screening are almost exclusively pharmacological in nature.
The drugs recommended by TMAP are both dangerous and ineffective - they all carry Black Box warning labels.
2) The diagnostic criteria upon which mental health screening instruments rest are scientifically invalid, vague, and entirely open to subjective interpretation.
· Indeed, in 1999, the US Surgeon General  acknowledged: "what it means to be mentally healthy is subject to many different interpretations that are rooted in value judgments that may vary across cultures." The clinician's guide to diagnosing mental disorders, the DSM IV, acknowledges: "The DSM-IV  criteria remain a consensus without clear empirical data...the behavioral characteristics specified in DSM-IV, despite efforts to standardize them, remain subjective . . . " p.1163
"In the last year ... Has there been a time when you felt you couldn't do anything well or that you weren't as good-looking or as smart as other people?"
"In the last year...Has there been a time when you couldn't think as clearly or as fast as usual?"
"Have you often felt very nervous when you've had to do things in front of people?"
·TeenScreen (a.k.a. Columbia SuicideScreen, CSS) is an illegitimate intrusion on privacy which purports to be a suicide prevention assessment tool but lacks any semblance of scientific validity. Indeed, the results of a study by Dr. David Shaffer, Chairman of Child and Adolescent Psychiatry, Columbia University, who is credited with developing and promoting TeenScreen, show that of 1,729 New York City high school students who were screened using the TeenScreen questionnaire, 475 students tested positive.
· He acknowledges that "Two hundred and three (77 percent) of the 262 teens who screened positive at follow up had no evidence of depression or suicidality at follow-up." 9
A child who is mislabeled as "mentally ill" is likely to be harmed emotionally, psychologically and neurologically - especially if prescribed powerful psychoactive drugs.
"Childhood and adolescence being developmental phases, it is difficult to draw clear boundaries between phenomena that are part of normal development and others that are abnormal." [World Health Organization]
By pathologizing children's normal developmental changes and emotional expression, nonconforming (often gifted) children are mislabeled as mentally ill. That label stigmatizes them and sets limits on their choices and, therefore, their mental well-being. Promoters of mental health screening fail to acknowledge that children who test "positive" at high risk of being prescribed pharmacological treatments that are not approved for children; that have been shown to be mostly ineffective in industry's own studies; that even during short-term tests have triggered severe, sometimes fatal side effects. Indeed, most of the psychotropic drugs prescribed for children carry Black Box warnings - FDA's strongest safety alert.
"More than two-thirds of studies of antidepressants given to depressed children, for instance, found the medications were no better than sugar pills, but companies published only the positive trials."
"FDA has concluded that suicidal thinking or behavior may increase in pediatric patients treated with any type of antidepressant, especially early in treatment.
Increases in suicidal thinking or behavior due to drug can be expected in about 1 out of 50 treated pediatric patients." 
4) Despite its proven unreliability as a predictive tool, and no evidence that mental screening prevents suicide , TeenScreen promotes itself in direct to consumer marketing advertisements - as a suicide prevention tool, proving that science is no deterrent for a marketing strategy.
TeenScreen promoters are misinforming public health policy makers, school officials, families and teens by mischaracterizing their experimental, scientifically invalid questionnaire as a proven suicide prevention strategy, when their own research refutes such claims. TeenScreen's low predictive level - shown to be only 16% - will result in falsely labeling 84% of children who test positive as mentally ill or suicidal.11 As acknowledged by Dr. Shaffer, such a high rate of false positives "could reduce the acceptability of a school-based prevention program." TeenScreen seemingly driven by marketing considerations continues to make unfounded claims that belie the evidence. As a result, healthy children are increasingly prescribed psychotropic drugs that have been shown to be harmful.
AHRP is dismayed that the government is wasting tens of millions of taxpayers' dollars for scientifically invalid mental health screening programs that are more likely to harm than help children. Most recently the federal Substance Abuse Mental Health Services Administration (SAMHSA) awarded $9.7 million  to support 37 "suicide prevention" screening programs.
"If the screening will be given to all students, as opposed to some, it becomes part of the curriculum and no longer requires active parental consent (i.e., if all ninth graders will be screened as a matter of policy), it is considered part of the curriculum." 
5) Coercive mental health screening and forced drugging is already happening to children in the United States. Current estimates "Each year, eight million American children, or about 10% of the school-age population, are prescribed mind altering drugs.
6) Finally, a radical proposal contained in the Federal Mental Health Action Agenda (FMHAA) - a follow-up to the NFC, is alarming as it is preposterous. The FMHAA stated goal is: to "develop mental health promotion and early intervention services targeted to infants, toddlers, preschool, and school-aged children." 
"Psychopharmacology is on the horizon as preventive therapy for children with genetic susceptibility to mental health problems."  (Emphasis added).
AHRP opposes psychiatric screening of children without active, informed, parental consent. Consent of parents must be documented and given voluntarily without a hint of coercion. TeenScreen has attempted to side-step parental consent by claiming "passive parental consent" - which is invalid.
The FDA bears responsibility for failing to stop an unethical drug marketing strategy that is increasing the risk of serious harm for healthy children who are being misprescribed psychoactive drugs on the basis of an invalid screening tool that was being promoted with false claims. According to its website, as of October 25, 2005, TeenScreen is actively operating at 460 locations in 42 states and Washington DC. 
 Wilson N., KEYE News Investigates. (July 23, 2004) Psychiatric drugs and (September 30, 2004) Drugs and your tax dollars. http://keyetv.com/investigativevideo
 Dr. Weiden quoted by Lenzer, Jeanne (5/15/04) British Medical Journal, http://bmj.bmjjournals.com/cgi/content/full/bmj;328/7449/1153
 AHRP (11/13/04) Texas Foster Care Investigation - Children as young as 3 are drugged with antipsychotics http://www.ahrp.org/infomail/04/11/13.php
 AHRP (8/11/04) Two-thirds foster care children in Mass on psych drugs - Globe http://www.ahrp.org/infomail/04/08/11.php
 AHRP (9/24/03) Babies given mind altering drugs in Florida http://www.ahrp.org/infomail/03/09/24.php
 Surgeon General's Report on Mental Health, (1999) p. 7 of pdf, http://www.surgeongeneral.gov/library/mentalhealth/pdfs/c3.pdf
 American Psychiatric Association Committee on the Diagnostic and Statistical Manual (DSM IV- 1994), pp.1162-1163
 David Shaffer, et al (date ?) High-school screening for suicidality: Implications for young adults, American Foundation for Suicide Prevention, http://www.afsp.org/education/shaff_pc.htm
 Andrew Harding. (December 7, 2004) Japan's Internet "Suicide Clubs" BBC Asia
 David Shaffer et al. (2004). The Columbia SuicideScreen: Validity and Reliability of a Screen for Youth Suicide and Prevention. Journal of the American Academy of Child and Adolescent Psychiatry, 43(1), 71-79; p. 77.
 Vitiello, B. (10/2001) Psychopharmacology for Young Children: Clinical Needs and Research Opportunities Pediatrics, Vol. 108, No. 4, pp. 983-989
 M. ALEXANDER OTTO. (September 13, 2005) Are ADHD drugs safe? Report finds little proof; The News Tribune. See: http://www.ahrp.org/infomail/05/09/13a.php
 Vedatam, S. (September 20, 2005) New Antipsychotic Drugs Criticized, Federal Study Finds No Benefit Over Older, Cheaper Drug, Washington Post, p. A01; and Carey, B. Study Finds Little Advantage in New Schizophrenia Drug (9/20/05) New York Times, p. F-1. See: http://www.ahrp.org/infomail/05/09/20.php
 US Preventative Services Task Force (5/18/04) Screening for Suicide Risk http://www.ahrq.gov/clinic/3rduspstf/suicide/suiciderr.htm#clinical
 News from NYS Office of Mental Health http://www.eisinc.com/release/storiesh/NYSOMH.138.html
 TeenScreen News (Fall 2003 ) http://www.antidepressantsfacts.com/TeenScreen-crimin.pdf
 Waters, R. (May/June 2005) Medicating Aliah, Mother Jones, http://www.motherjones.com/news/feature/2005/05/medicating_aliah.html, enter code MJZL6Y
 Montero, D., (8/7/02) I was forced to dope my kid, The New York Post at http://www.nypost.com/news/regionalnews/54243.htm last visited 8/30/02
 Karlin, R. (7/19/00) Court orders couple to give son drug (Ritalin) after school turns parents in, Albany Times Union)
 Eagle Forum (June, 2002) A Parent's Nightmare: Losing a Child to Drug-Induced Psychosis, Education Reporter, http://www.eagleforum.org/educate/2002/june02/drug-induced.shtml last visited 5/13/03
 Vitiello, B. (2001) Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics. 108: 983-990.
 David W. Willis, M.D. ((January, 2004) Medical Director of the Northwest Early Childhood Institute in Portland, Oregon, as quoted in Pediatric News
 Sharav, VH. (Summer 2005) Screening for Mental Illness: The Merger of Eugenics and the Drug Industry Ethical Human Psychology and Psychiatry Volume 7, Number 2.http://www.teenscreen.org/cms/index.php?option=content&task=view&id=81&Itemid=113